Abstract
Over the past years, new systemic therapies for advanced and metastatic breast cancer have emerged, resulting in significantly improved survival outcomes in this patient population. This article provides a summary of selected clinically relevant studies presented at the 2021 European Society for Medical Oncology (ESMO) Congress, American Society of Clinical Oncology (ASCO) Annual Meeting and San Antonio Breast Cancer Symposium (SABCS), including updated results from pivotal trials and new data on emerging therapies.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
